enVVeno Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	0	0	0	0	0.03	0.19	0.42	0.79
Revenue Growth (YoY)	-	-	-	-	-83.25%	-55.80%	-46.29%	-
Cost of Revenue	0	0	0	0	0	0	0.42	0.81
Gross Profit	0	0	0	0	0.03	0.19	0	-0.02
Selling, General & Admin	11.66	15.02	11.17	4.88	4.91	6.48	5.46	4.63
Research & Development	13.58	9.91	5.73	4.25	2.21	1.24	0.65	0
Other Operating Expenses	0	0	0	0	0.59	0.32	0	0
Operating Expenses	25.24	24.93	16.89	9.14	7.71	8.04	6.11	4.63
Operating Income	-25.24	-24.93	-16.89	-9.14	-7.68	-7.85	-6.1	-4.66
Interest Expense / Income	0	0	0	-0	-0.05	0.3	0.21	0.06
Other Expense / Income	-1.72	-0.26	-0.37	0	-	4.89	1.48	-1.33
Pretax Income	-23.52	-24.67	-16.53	-9.14	-7.63	-13.04	-7.79	-3.39
Net Income	-23.52	-24.67	-16.53	-9.14	-7.63	-13.04	-7.79	-3.39
Preferred Dividends	0	0	0	0.61	0	3.31	0.46	0.34
Net Income Common	-23.52	-24.67	-16.53	-9.74	-7.63	-16.35	-8.25	-3.73
Shares Outstanding (Basic)	12	11	9	1	1	0	0	0
Shares Outstanding (Diluted)	12	11	9	1	1	0	0	0
Shares Change	9.54%	29.38%	572.10%	104.86%	68.34%	52.81%	1.42%	-
EPS (Basic)	-1.91	-2.20	-1.90	-7.54	-12.10	-43.75	-33.75	-15.50
EPS (Diluted)	-1.91	-2.20	-1.90	-7.54	-12.10	-43.75	-33.75	-15.50
Free Cash Flow	-18.89	-15.73	-12.22	-7.86	-6.26	-6.37	-4.21	-3.42
Free Cash Flow Per Share	-1.54	-1.40	-1.41	-6.08	-9.93	-17.00	-17.19	-14.15
Gross Margin	-	-	-	-	100.00%	100.00%	0.58%	-3.10%
Operating Margin	-	-	-	-	-24566.50%	-4210.51%	-1445.89%	-592.84%
Profit Margin	-	-	-	-	-24406.74%	-8765.77%	-1954.79%	-474.65%
Free Cash Flow Margin	-	-	-	-	-20037.42%	-3413.66%	-998.12%	-435.24%
EBITDA	-22.97	-24.14	-16.08	-8.76	-7.28	-12.61	-7.44	-3.18
EBITDA Margin	-	-	-	-	-23296.90%	-6760.11%	-1763.22%	-404.43%
Depreciation & Amortization	0.55	0.53	0.45	0.38	0.4	0.13	0.14	0.15
EBIT	-23.52	-24.67	-16.53	-9.14	-7.68	-12.74	-7.58	-3.33
EBIT Margin	-	-	-	-	-24566.50%	-6831.63%	-1796.20%	-423.66%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).